.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Express Scripts
Fish and Richardson
Mallinckrodt
Cipla
Cerilliant
Federal Trade Commission
Chinese Patent Office
AstraZeneca

Generated: November 20, 2017

DrugPatentWatch Database Preview

TRAVASOL 3.5% W/ ELECTROLYTES Drug Profile

« Back to Dashboard

What is the patent landscape for Travasol 3.5% W/ Electrolytes, and what generic Travasol 3.5% W/ Electrolytes alternatives are available?

Travasol 3.5% W/ Electrolytes is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in TRAVASOL 3.5% W/ ELECTROLYTES is amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and forty-one drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.

Summary for TRAVASOL 3.5% W/ ELECTROLYTES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER
amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
INJECTABLE;INJECTION020177-001Oct 23, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
TRAVASOL 3.5% W/ ELECTROLYTES
amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
INJECTABLE;INJECTION017493-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Cerilliant
Accenture
Cantor Fitzgerald
Merck
QuintilesIMS
Citi
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot